Gardasil 00006-4045-41
Generic: Human Papillomavirus Quadrivalent (types 6, 11, 16, And 18) Vaccine, Recombinant
- Manufacturer
- Merck Sharp & Dohme Llc
- Dosage Form
- Injection, Suspension
- Route
- Intramuscular
- Product Type
- Vaccine
- Marketing Start
- June 8, 2006
- Listing Expires
- December 31, 2026
- Application
- BLA125126
Active Ingredients
| Ingredient | Strength |
|---|---|
| Human Papillomavirus Type 11 L1 Capsid Protein Antigen | 40 ug/.5mL |
| Human Papillomavirus Type 16 L1 Capsid Protein Antigen | 40 ug/.5mL |
| Human Papillomavirus Type 18 L1 Capsid Protein Antigen | 20 ug/.5mL |
| Human Papillomavirus Type 6 L1 Capsid Protein Antigen | 20 ug/.5mL |
Drug Class
Actively Acquired Immunity [PE]Actively Acquired Immunity [PE]Actively Acquired Immunity [PE]
Selected Package
00006-4045-41Selected10 VIAL, SINGLE-DOSE in 1 CARTON (0006-4045-41) / .5 mL in 1 VIAL, SINGLE-DOSE (0006-4045-01)
Other packages for this product(1)
1 VIAL, SINGLE-DOSE in 1 CARTON (0006-4045-00) / .5 mL in 1 VIAL, SINGLE-DOSE (0006-4045-01)
Related Products
All Human Papillomavirus Quadrivalent (types 6, 11, 16, And 18) Vaccine, Recombinant NDC codes →External Resources